drugset / Trial / NCT01889745
A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.
Summary
This study is designed to multiple dose and dose escalation study
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HX-1171 | Small molecule | 500 mg | — |
Indications
No indication recorded.